drugset / Trial / NCT02848417
Glutathione vs. Curcumin Clinical Trial
RandomizedParallel-groupDouble-blindTreatment
Summary
The investigator proposes to perform a phase I/II study comparing two nutraceuticals and placebo that target mediators identified in the investigator's prior dynamic modeling study of Gulf War Illness (GWI). The investigator will repeat the dynamic modeling before treatment and on therapy to assess the modeling and the impact of the interventions on the homeostatic networks that have identified, with an added focus on the glutathione/redox system.
Timeline
- Start
- 2016-04
- Primary completion
- 2019-08
- Completion
- 2020-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Curcumin | Small molecule | 400 mg | Oral |
| Subject | Glutathione | Peptide | 630 mg | Oral |